Acceleron Pharma, Inc.: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $592K
- Providers paid
- 771
- Transactions
- 1,347
- Average per transaction
- $439
The average per transaction — $439 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| Oregon | $107,157 | 18.1% |
| California | $67,028 | 11.3% |
| Florida | $65,014 | 11.0% |
| Kansas | $48,339 | 8.2% |
| Minnesota | $43,013 | 7.3% |
| Texas | $37,837 | 6.4% |
| Arizona | $30,124 | 5.1% |
| Tennessee | $23,037 | 3.9% |
| New York | $21,011 | 3.6% |
| Massachusetts | $20,392 | 3.4% |
| Pennsylvania | $16,213 | 2.7% |
| Ohio | $13,033 | 2.2% |
| Michigan | $12,840 | 2.2% |
| Missouri | $11,956 | 2.0% |
| Washington | $9,458 | 1.6% |
| North Carolina | $9,325 | 1.6% |
| Virginia | $8,740 | 1.5% |
| Illinois | $7,810 | 1.3% |
| Colorado | $7,462 | 1.3% |
| New Jersey | $6,359 | 1.1% |
| South Carolina | $5,500 | 0.9% |
| Nevada | $4,000 | 0.7% |
| Maine | $3,200 | 0.5% |
| Kentucky | $2,907 | 0.5% |
| Indiana | $2,320 | 0.4% |
| Mississippi | $2,166 | 0.4% |
| Maryland | $1,116 | 0.2% |
| District of Columbia | $1,111 | 0.2% |
| Alabama | $983 | 0.2% |
| Arkansas | $759 | 0.1% |
| Louisiana | $605 | 0.1% |
| Georgia | $431 | 0.1% |
| Oklahoma | $174 | 0.0% |
| Montana | $29 | 0.0% |
| XX | $27 | 0.0% |
| Idaho | $25 | 0.0% |
| Hawaii | $19 | 0.0% |
| West Virginia | $15 | 0.0% |
| Connecticut | $14 | 0.0% |
| Utah | $13 | 0.0% |
Products named in Acceleron Pharma, Inc.'s payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- Reblozyl$298,873